Skip to content

Public FDA record

Z-1296-2025: BD BBL TB Stain Kit K, Catalog (REF): 212522

Recall record Z-1296-2025 for Becton Dickinson & Co.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1296-2025
Company in FDA record
Becton Dickinson & Co.
FDA classification date
Mar 6, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

One component of the kit was shipped with an expiration date of 30Sep2024 while the Certificate of Analysis (COA) indicated an expiration date of 30Apr2025.

Source facts

Action
On February 12, 2025 URGENT: MEDICAL DEVICE PRODUCT REMOVAL letters were sent to distributors. Please Take the Following Actions: 1. Immediately inspect your inventory for the specific catalog and lot number listed to determine if the lot in your possession are impacted and immediately discard any remaining inventory of the affected product. 2. Ensure the contents of this notification are read and understood. 3. Identify all customers within your distribution network that purchased any affected product as defined in this Product Recall. Provide a copy of the attached customer letter to all customers who received the affected lots to advise them of this Product Recall on BD s behalf. 4. Complete the attached Distributor Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification. BD is committed to advancing the world of health. Our primary objectives are patient and user safety and providing you with quality products. We apologize for any inconvenience this issue may have caused you and thank you in advance for helping us to resolve this matter as quickly and effectively as possible. On February 12, 2025 URGENT: MEDICAL DEVICE PRODUCT REMOVAL letters were sent to customers. Actions for Customers: 1) Immediately inspect your inventory for the specific catalog and lot number listed todetermine if the lot in your possession are impacted and immediately discard any remaining inventory of the affected product. 2) Ensure the contents of this notification are read and understood by those within yourorganization. 3) Share and post this customer letter with users of this application at your facility andforward to any customers to whom you may have distributed the product to ensureawareness. 4) Complete the attached Customer Response Form and return to the BD contactnoted on the form whether or not you have any of the impacted material so that BDmay acknowledge
Initiated
2025-02-12
Root cause
Under Investigation by firm
Distribution
Domestic: AZ, CA, CO, GA, KY, IL, IN, NC, NJ, NY, MA, MD, TX, WA. International: Singapore, New Zealand, Chile, Australia, Taiwan, Malaysia.
Recall number
Z-1296-2025
Recall status
Open, Classified
CDRH record ID
212412
FDA classified
2025-03-06
Recall event number
96244

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗